,Gene_set,Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes
0,GO_Biological_Process_2018,regulation of synapse assembly (GO:0051963),2/35,0.0005541829397838258,0.0399011716644354,0,0,67.16161616161617,503.57885305588366,ROBO2;PTPRD
83,GO_Biological_Process_2017b,medial motor column neuron differentiation (GO:0021526),2/63,0.001788774259171,0.0477340577756805,0,0,36.28233151183971,229.5301805177287,PTPRD;MYT1L
82,GO_Biological_Process_2017b,retinal bipolar neuron differentiation (GO:0060040),2/63,0.001788774259171,0.0477340577756805,0,0,36.28233151183971,229.5301805177287,PTPRD;MYT1L
81,GO_Biological_Process_2017b,photoreceptor cell differentiation (GO:0046530),2/63,0.001788774259171,0.0477340577756805,0,0,36.28233151183971,229.5301805177287,PTPRD;MYT1L
80,GO_Biological_Process_2017b,mechanoreceptor differentiation (GO:0042490),2/63,0.001788774259171,0.0477340577756805,0,0,36.28233151183971,229.5301805177287,PTPRD;MYT1L
79,GO_Biological_Process_2017b,central nervous system neuron differentiation (GO:0021953),3/159,0.0005088865864018103,0.0477340577756805,0,0,22.42533936651584,170.057748221093,ROBO2;PTPRD;MYT1L
86,GO_Biological_Process_2017b,neuron differentiation involved in salivary gland development (GO:0060705),2/63,0.001788774259171,0.0477340577756805,0,0,36.28233151183971,229.5301805177287,PTPRD;MYT1L
87,GO_Biological_Process_2017b,Rohon-Beard neuron differentiation (GO:1905275),2/63,0.001788774259171,0.0477340577756805,0,0,36.28233151183971,229.5301805177287,PTPRD;MYT1L
88,GO_Biological_Process_2017b,GABAergic neuron differentiation (GO:0097154),2/64,0.0018453715711163,0.0477340577756805,0,0,35.69534050179212,224.7048323380627,PTPRD;MYT1L
89,GO_Biological_Process_2017b,cardiac neuron differentiation (GO:0060945),2/66,0.001961104016553,0.0477340577756805,0,0,34.576388888888886,215.55777257871145,PTPRD;MYT1L
90,GO_Biological_Process_2017b,noradrenergic neuron differentiation (GO:0003357),2/67,0.0020202359976765,0.0477340577756805,0,0,34.042735042735046,211.21954341363585,PTPRD;MYT1L
91,GO_Biological_Process_2017b,neuron fate commitment (GO:0048663),2/68,0.0020802097196089,0.0477340577756805,0,0,33.525252525252526,207.02804146104276,PTPRD;MYT1L
92,GO_Biological_Process_2017b,amacrine cell differentiation (GO:0035881),2/68,0.0020802097196089,0.0477340577756805,0,0,33.525252525252526,207.02804146104276,PTPRD;MYT1L
93,GO_Biological_Process_2017b,neuron differentiation (GO:0030182),2/70,0.0022026761035863,0.0477340577756805,0,0,32.5359477124183,199.05760409273051,PTPRD;MYT1L
94,GO_Biological_Process_2017b,hair cell differentiation (GO:0035315),2/72,0.0023284906232039,0.0477340577756805,0,0,31.603174603174605,191.59535285451057,PTPRD;MYT1L
84,GO_Biological_Process_2017b,glutamatergic neuron differentiation (GO:1905962),2/63,0.001788774259171,0.0477340577756805,0,0,36.28233151183971,229.5301805177287,PTPRD;MYT1L
85,GO_Biological_Process_2017b,neuron differentiation involved in amphid sensory organ development (GO:0003387),2/63,0.001788774259171,0.0477340577756805,0,0,36.28233151183971,229.5301805177287,PTPRD;MYT1L
96,GO_Biological_Process_2017b,dopaminergic neuron differentiation (GO:0071542),2/78,0.0027258980360561,0.0496719197681348,0,0,29.09941520467836,171.83080571225088,PTPRD;MYT1L
95,GO_Biological_Process_2017b,peripheral nervous system neuron differentiation (GO:0048934),2/77,0.0026575929845639,0.0496719197681348,0,0,29.488888888888887,174.87897393163863,PTPRD;MYT1L
1,GO_Biological_Process_2018,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),2/58,0.0015185400416673,0.0546674415000253,0,0,39.53174603174603,256.5612651652447,ROBO2;PTPRD
97,GO_Biological_Process_2017b,neuron development (GO:0048666),2/86,0.0033018930995042,0.0570011019282843,0,0,26.31746031746032,150.3584751342039,PTPRD;MYT1L
12,GO_Biological_Process_2018,negative regulation of chemotaxis (GO:0050922),1/11,0.0109477797028559,0.0606338568158177,0,0,105.10526315789474,474.5101770765117,ROBO2
10,GO_Biological_Process_2018,presynaptic membrane assembly (GO:0097105),1/10,0.0099572476243861,0.0606338568158177,0,0,116.78947368421052,538.3357753631753,PTPRD
9,GO_Biological_Process_2018,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),2/142,0.0087462104643365,0.0606338568158177,0,0,15.746031746031743,74.62256641453148,ROBO2;PTPRD
8,GO_Biological_Process_2018,neuron differentiation (GO:0030182),2/139,0.0083942929149811,0.0606338568158177,0,0,16.093268450932683,76.9290936521396,PTPRD;MYT1L
11,GO_Biological_Process_2018,presynaptic membrane organization (GO:0097090),1/11,0.0109477797028559,0.0606338568158177,0,0,105.10526315789474,474.5101770765117,PTPRD
6,GO_Biological_Process_2018,neuron fate specification (GO:0048665),1/7,0.0069799958941807,0.0606338568158177,0,0,175.21052631578948,869.8689177892479,MYT1L
5,GO_Biological_Process_2018,negative regulation of synapse organization (GO:1905809),1/7,0.0069799958941807,0.0606338568158177,0,0,175.21052631578948,869.8689177892479,ROBO2
4,GO_Biological_Process_2018,transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185),1/6,0.0059856908667451,0.0606338568158177,0,0,210.26315789473685,1076.2074808846232,PTPRD
3,GO_Biological_Process_2018,retinal ganglion cell axon guidance (GO:0031290),1/6,0.0059856908667451,0.0606338568158177,0,0,210.26315789473685,1076.2074808846232,ROBO2
2,GO_Biological_Process_2018,positive regulation of cellular component organization (GO:0051130),2/106,0.0049676024043447,0.0606338568158177,0,0,21.235042735042736,112.64803627089996,PTPRD;LMAN1
7,GO_Biological_Process_2018,generation of neurons (GO:0048699),2/130,0.0073783141926676,0.0606338568158177,0,0,17.23263888888889,84.5986448078777,PTPRD;MYT1L
13,GO_Biological_Process_2018,regulation of neurotransmitter transport (GO:0051588),1/13,0.0129260209528938,0.0620449005738905,0,0,87.57894736842105,380.8381798737429,CPLX4
14,GO_Biological_Process_2018,neuron fate commitment (GO:0048663),1/13,0.0129260209528938,0.0620449005738905,0,0,87.57894736842105,380.8381798737429,MYT1L
106,GO_Biological_Process_2017b,subpallium neuron fate commitment (GO:0060163),1/8,0.0079733565142536,0.0621771350569138,0,0,150.17293233082708,725.5830081396662,MYT1L
111,GO_Biological_Process_2017b,neuron fate determination (GO:0048664),1/8,0.0079733565142536,0.0621771350569138,0,0,150.17293233082708,725.5830081396662,MYT1L
110,GO_Biological_Process_2017b,spinal cord association neuron specification (GO:0021519),1/8,0.0079733565142536,0.0621771350569138,0,0,150.17293233082708,725.5830081396662,MYT1L
109,GO_Biological_Process_2017b,somatic motor neuron fate commitment (GO:0021917),1/8,0.0079733565142536,0.0621771350569138,0,0,150.17293233082708,725.5830081396662,MYT1L
108,GO_Biological_Process_2017b,ventral spinal cord interneuron specification (GO:0021521),1/8,0.0079733565142536,0.0621771350569138,0,0,150.17293233082708,725.5830081396662,MYT1L
107,GO_Biological_Process_2017b,cardiac neuron fate commitment (GO:0060960),1/8,0.0079733565142536,0.0621771350569138,0,0,150.17293233082708,725.5830081396662,MYT1L
105,GO_Biological_Process_2017b,positive regulation of chromosome organization (GO:2001252),1/7,0.0069799958941807,0.0621771350569138,0,0,175.21052631578948,869.8689177892479,LMAN1
147,GO_Biological_Process_2017b,nucleoside phosphate metabolic process (GO:0006753),1/16,0.0158863378646896,0.0621771350569138,0,0,70.05263157894737,290.1787210723924,PTPRD
103,GO_Biological_Process_2017b,auditory receptor cell fate specification (GO:0042667),1/7,0.0069799958941807,0.0621771350569138,0,0,175.21052631578948,869.8689177892479,MYT1L
102,GO_Biological_Process_2017b,positive regulation of vacuole organization (GO:0044090),1/6,0.0059856908667451,0.0621771350569138,0,0,210.26315789473685,1076.2074808846232,LMAN1
101,GO_Biological_Process_2017b,positive regulation of peroxisome organization (GO:1900064),1/6,0.0059856908667451,0.0621771350569138,0,0,210.26315789473685,1076.2074808846232,LMAN1
100,GO_Biological_Process_2017b,negative regulation of synapse assembly (GO:0051964),1/6,0.0059856908667451,0.0621771350569138,0,0,210.26315789473685,1076.2074808846232,ROBO2
99,GO_Biological_Process_2017b,positive regulation of endoplasmic reticulum tubular network organization (GO:1903373),1/6,0.0059856908667451,0.0621771350569138,0,0,210.26315789473685,1076.2074808846232,LMAN1
98,GO_Biological_Process_2017b,photoreceptor cell fate specification (GO:0043704),1/6,0.0059856908667451,0.0621771350569138,0,0,210.26315789473685,1076.2074808846232,MYT1L
112,GO_Biological_Process_2017b,photoreceptor cell fate commitment (GO:0046552),1/8,0.0079733565142536,0.0621771350569138,0,0,150.17293233082708,725.5830081396662,MYT1L
104,GO_Biological_Process_2017b,spinal cord commissural neuron specification (GO:0021518),1/7,0.0069799958941807,0.0621771350569138,0,0,175.21052631578948,869.8689177892479,MYT1L
148,GO_Biological_Process_2017b,O3-(N-acetylglucosamine-1-phosphoryl)-L-serine biosynthetic process (GO:0018425),1/16,0.0158863378646896,0.0621771350569138,0,0,70.05263157894737,290.1787210723924,PTPRD
113,GO_Biological_Process_2017b,cerebral cortex GABAergic interneuron fate commitment (GO:0021893),1/8,0.0079733565142536,0.0621771350569138,0,0,150.17293233082708,725.5830081396662,MYT1L
115,GO_Biological_Process_2017b,inner ear receptor cell fate commitment (GO:0060120),1/9,0.0089657734963174,0.0621771350569138,0,0,131.39473684210526,619.439581424405,MYT1L
146,GO_Biological_Process_2017b,6-sulfoquinovose(1-) catabolic process to 3-sulfopropanediol(1-) (GO:0061721),1/16,0.0158863378646896,0.0621771350569138,0,0,70.05263157894737,290.1787210723924,PTPRD
145,GO_Biological_Process_2017b,6-sulfoquinovose(1-) catabolic process to glycerone phosphate and 3-sulfolactaldehyde (GO:0061720),1/16,0.0158863378646896,0.0621771350569138,0,0,70.05263157894737,290.1787210723924,PTPRD
144,GO_Biological_Process_2017b,ureteric bud development (GO:0001657),1/16,0.0158863378646896,0.0621771350569138,0,0,70.05263157894737,290.1787210723924,ROBO2
143,GO_Biological_Process_2017b,metanephric collecting duct development (GO:0072205),1/16,0.0158863378646896,0.0621771350569138,0,0,70.05263157894737,290.1787210723924,ROBO2
142,GO_Biological_Process_2017b,1-deoxy-D-xylulose 5-phosphate metabolic process (GO:0052863),1/16,0.0158863378646896,0.0621771350569138,0,0,70.05263157894737,290.1787210723924,PTPRD
141,GO_Biological_Process_2017b,ribose phosphate metabolic process (GO:0019693),1/16,0.0158863378646896,0.0621771350569138,0,0,70.05263157894737,290.1787210723924,PTPRD
140,GO_Biological_Process_2017b,ureter part of ureteric bud development (GO:0035503),1/15,0.0149005037888985,0.0621771350569138,0,0,75.06015037593986,315.7300332957057,ROBO2
139,GO_Biological_Process_2017b,ureteric bud morphogenesis (GO:0060675),1/15,0.0149005037888985,0.0621771350569138,0,0,75.06015037593986,315.7300332957057,ROBO2
138,GO_Biological_Process_2017b,metanephros morphogenesis (GO:0003338),1/15,0.0149005037888985,0.0621771350569138,0,0,75.06015037593986,315.7300332957057,ROBO2
137,GO_Biological_Process_2017b,anterior/posterior pattern specification involved in ureteric bud development (GO:0072099),1/14,0.01391373176082,0.0621771350569138,0,0,80.83805668016194,345.57291333057793,ROBO2
136,GO_Biological_Process_2017b,noradrenergic neuron fate commitment (GO:0003359),1/13,0.0129260209528938,0.0621771350569138,0,0,87.57894736842105,380.8381798737429,MYT1L
135,GO_Biological_Process_2017b,metanephric smooth muscle tissue development (GO:0072208),1/13,0.0129260209528938,0.0621771350569138,0,0,87.57894736842105,380.8381798737429,ROBO2
134,GO_Biological_Process_2017b,metanephric cortex development (GO:0072214),1/13,0.0129260209528938,0.0621771350569138,0,0,87.57894736842105,380.8381798737429,ROBO2
133,GO_Biological_Process_2017b,transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185),1/13,0.0129260209528938,0.0621771350569138,0,0,87.57894736842105,380.8381798737429,PTPRD
132,GO_Biological_Process_2017b,metanephric capsule development (GO:0072213),1/12,0.0119373705403343,0.0621771350569138,0,0,95.54545454545456,423.0830518492731,ROBO2
131,GO_Biological_Process_2017b,mesenchymal cell apoptotic process involved in metanephros development (GO:1900200),1/12,0.0119373705403343,0.0621771350569138,0,0,95.54545454545456,423.0830518492731,ROBO2
130,GO_Biological_Process_2017b,cell migration involved in metanephros development (GO:0035788),1/12,0.0119373705403343,0.0621771350569138,0,0,95.54545454545456,423.0830518492731,ROBO2
116,GO_Biological_Process_2017b,positive regulation of organelle assembly (GO:1902117),1/9,0.0089657734963174,0.0621771350569138,0,0,131.39473684210526,619.439581424405,LMAN1
117,GO_Biological_Process_2017b,olfactory bulb interneuron fate commitment (GO:0021890),1/10,0.0099572476243861,0.0621771350569138,0,0,116.78947368421052,538.3357753631753,MYT1L
118,GO_Biological_Process_2017b,spinal cord motor neuron cell fate specification (GO:0021520),1/10,0.0099572476243861,0.0621771350569138,0,0,116.78947368421052,538.3357753631753,MYT1L
119,GO_Biological_Process_2017b,regulation of transcription from RNA polymerase II promoter involved in metanephros development (GO:0072212),1/11,0.0109477797028559,0.0621771350569138,0,0,105.10526315789474,474.5101770765117,ROBO2
120,GO_Biological_Process_2017b,metanephric juxtaglomerular apparatus development (GO:0072206),1/11,0.0109477797028559,0.0621771350569138,0,0,105.10526315789474,474.5101770765117,ROBO2
121,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in neuron fate specification (GO:1904080),1/11,0.0109477797028559,0.0621771350569138,0,0,105.10526315789474,474.5101770765117,MYT1L
114,GO_Biological_Process_2017b,forebrain neuron fate commitment (GO:0021877),1/9,0.0089657734963174,0.0621771350569138,0,0,131.39473684210526,619.439581424405,MYT1L
149,GO_Biological_Process_2017b,D-tagatose 6-phosphate metabolic process (GO:2001058),1/16,0.0158863378646896,0.0621771350569138,0,0,70.05263157894737,290.1787210723924,PTPRD
124,GO_Biological_Process_2017b,metanephric pyramids development (GO:0072211),1/11,0.0109477797028559,0.0621771350569138,0,0,105.10526315789474,474.5101770765117,ROBO2
125,GO_Biological_Process_2017b,cell differentiation involved in metanephros development (GO:0072202),1/11,0.0109477797028559,0.0621771350569138,0,0,105.10526315789474,474.5101770765117,ROBO2
126,GO_Biological_Process_2017b,ventral spinal cord interneuron fate commitment (GO:0060579),1/11,0.0109477797028559,0.0621771350569138,0,0,105.10526315789474,474.5101770765117,MYT1L
127,GO_Biological_Process_2017b,neuron fate specification (GO:0048665),1/11,0.0109477797028559,0.0621771350569138,0,0,105.10526315789474,474.5101770765117,MYT1L
128,GO_Biological_Process_2017b,regulation of metanephric glomerulus development (GO:0072298),1/11,0.0109477797028559,0.0621771350569138,0,0,105.10526315789474,474.5101770765117,ROBO2
129,GO_Biological_Process_2017b,pattern specification involved in metanephros development (GO:0072268),1/12,0.0119373705403343,0.0621771350569138,0,0,95.54545454545456,423.0830518492731,ROBO2
123,GO_Biological_Process_2017b,cell-cell signaling involved in metanephros development (GO:0072204),1/11,0.0109477797028559,0.0621771350569138,0,0,105.10526315789474,474.5101770765117,ROBO2
122,GO_Biological_Process_2017b,metanephric nephron development (GO:0072210),1/11,0.0109477797028559,0.0621771350569138,0,0,105.10526315789474,474.5101770765117,ROBO2
155,GO_Biological_Process_2017b,alditol phosphate metabolic process (GO:0052646),1/16,0.0158863378646896,0.0621771350569138,0,0,70.05263157894737,290.1787210723924,PTPRD
153,GO_Biological_Process_2017b,carbamoyl phosphate metabolic process (GO:0070408),1/16,0.0158863378646896,0.0621771350569138,0,0,70.05263157894737,290.1787210723924,PTPRD
152,GO_Biological_Process_2017b,methanopterin-containing compound metabolic process (GO:2001115),1/16,0.0158863378646896,0.0621771350569138,0,0,70.05263157894737,290.1787210723924,PTPRD
167,GO_Biological_Process_2017b,molybdopterin cofactor metabolic process (GO:0043545),1/17,0.0168712348172723,0.0621771350569138,0,0,65.67105263157895,268.0787715603985,PTPRD
166,GO_Biological_Process_2017b,lipid X metabolic process (GO:2001289),1/17,0.0168712348172723,0.0621771350569138,0,0,65.67105263157895,268.0787715603985,PTPRD
165,GO_Biological_Process_2017b,metanephric part of ureteric bud development (GO:0035502),1/17,0.0168712348172723,0.0621771350569138,0,0,65.67105263157895,268.0787715603985,ROBO2
164,GO_Biological_Process_2017b,thiamine diphosphate metabolic process (GO:0042357),1/17,0.0168712348172723,0.0621771350569138,0,0,65.67105263157895,268.0787715603985,PTPRD
163,GO_Biological_Process_2017b,metanephric epithelium development (GO:0072207),1/17,0.0168712348172723,0.0621771350569138,0,0,65.67105263157895,268.0787715603985,ROBO2
162,GO_Biological_Process_2017b,L-methionine biosynthetic process from O-phospho-L-homoserine and cystathionine (GO:0019283),1/17,0.0168712348172723,0.0621771350569138,0,0,65.67105263157895,268.0787715603985,PTPRD
151,GO_Biological_Process_2017b,phosphate-containing compound metabolic process (GO:0006796),1/16,0.0158863378646896,0.0621771350569138,0,0,70.05263157894737,290.1787210723924,PTPRD
160,GO_Biological_Process_2017b,glyceraldehyde-3-phosphate metabolic process (GO:0019682),1/16,0.0158863378646896,0.0621771350569138,0,0,70.05263157894737,290.1787210723924,PTPRD
161,GO_Biological_Process_2017b,glucose 1-phosphate metabolic process (GO:0019255),1/16,0.0158863378646896,0.0621771350569138,0,0,70.05263157894737,290.1787210723924,PTPRD
150,GO_Biological_Process_2017b,xylulose 5-phosphate metabolic process (GO:0051167),1/16,0.0158863378646896,0.0621771350569138,0,0,70.05263157894737,290.1787210723924,PTPRD
156,GO_Biological_Process_2017b,D-glycero-D-manno-heptose 7-phosphate metabolic process (GO:2001060),1/16,0.0158863378646896,0.0621771350569138,0,0,70.05263157894737,290.1787210723924,PTPRD
154,GO_Biological_Process_2017b,deoxyribose phosphate metabolic process (GO:0019692),1/16,0.0158863378646896,0.0621771350569138,0,0,70.05263157894737,290.1787210723924,PTPRD
158,GO_Biological_Process_2017b,"cyclic 2,3-bisphospho-D-glycerate biosynthetic process (GO:1901369)",1/16,0.0158863378646896,0.0621771350569138,0,0,70.05263157894737,290.1787210723924,PTPRD
159,GO_Biological_Process_2017b,phosphagen metabolic process (GO:0006599),1/16,0.0158863378646896,0.0621771350569138,0,0,70.05263157894737,290.1787210723924,PTPRD
157,GO_Biological_Process_2017b,presynaptic membrane assembly (GO:0097105),1/16,0.0158863378646896,0.0621771350569138,0,0,70.05263157894737,290.1787210723924,PTPRD
168,GO_Biological_Process_2017b,metanephric mesenchyme development (GO:0072075),1/18,0.0178551954764704,0.063657653437851,0,0,61.80495356037152,248.79341471282052,ROBO2
169,GO_Biological_Process_2017b,"7,8-dihydroneopterin 3'-triphosphate biosynthetic process (GO:0035998)",1/18,0.0178551954764704,0.063657653437851,0,0,61.80495356037152,248.79341471282052,PTPRD
170,GO_Biological_Process_2017b,"fructose 2,6-bisphosphate metabolic process (GO:0006003)",1/18,0.0178551954764704,0.063657653437851,0,0,61.80495356037152,248.79341471282052,PTPRD
15,GO_Biological_Process_2018,presynapse assembly (GO:0099054),1/15,0.0149005037888985,0.0639331003601899,0,0,75.06015037593986,315.7300332957057,PTPRD
18,GO_Biological_Process_2018,mesonephric tubule development (GO:0072164),1/17,0.0168712348172723,0.0639331003601899,0,0,65.67105263157895,268.0787715603985,ROBO2
17,GO_Biological_Process_2018,ureteric bud development (GO:0001657),1/17,0.0168712348172723,0.0639331003601899,0,0,65.67105263157895,268.0787715603985,ROBO2
16,GO_Biological_Process_2018,positive regulation of dendrite morphogenesis (GO:0050775),1/16,0.0158863378646896,0.0639331003601899,0,0,70.05263157894737,290.1787210723924,PTPRD
171,GO_Biological_Process_2017b,pyridoxal phosphate metabolic process (GO:0042822),1/19,0.0188382206720142,0.0650414355833755,0,0,58.36842105263158,231.8316321803268,PTPRD
173,GO_Biological_Process_2017b,positive regulation of mitochondrion organization (GO:0010822),1/19,0.0188382206720142,0.0650414355833755,0,0,58.36842105263158,231.8316321803268,LMAN1
172,GO_Biological_Process_2017b,GDP-mannose biosynthetic process from fructose-6-phosphate (GO:0061729),1/19,0.0188382206720142,0.0650414355833755,0,0,58.36842105263158,231.8316321803268,PTPRD
174,GO_Biological_Process_2017b,glucose 6-phosphate metabolic process (GO:0051156),1/20,0.019820311238232,0.0677193967306263,0,0,55.29362880886426,216.80897525048425,PTPRD
175,GO_Biological_Process_2017b,tyrosine catabolic process to phosphoenolpyruvate (GO:0019446),1/21,0.0208014680109953,0.0703389846144996,0,0,52.526315789473685,203.4203291515269,PTPRD
176,GO_Biological_Process_2017b,fructose 6-phosphate metabolic process (GO:0006002),1/22,0.0217816918149241,0.0729019889315827,0,0,50.02255639097744,191.42059056605152,PTPRD
178,GO_Biological_Process_2017b,positive regulation of mitotic nuclear envelope disassembly (GO:1905559),1/23,0.0227609834903901,0.0739168572757223,0,0,47.74641148325359,180.6107068727385,LMAN1
179,GO_Biological_Process_2017b,"fructose 1,6-bisphosphate metabolic process (GO:0030388)",1/23,0.0227609834903901,0.0739168572757223,0,0,47.74641148325359,180.6107068727385,PTPRD
177,GO_Biological_Process_2017b,glycerol to glycerone phosphate metabolic process (GO:0061610),1/23,0.0227609834903901,0.0739168572757223,0,0,47.74641148325359,180.6107068727385,PTPRD
19,GO_Biological_Process_2018,negative regulation of nervous system development (GO:0051961),1/22,0.0217816918149241,0.0744904914230949,0,0,50.02255639097744,191.42059056605152,ROBO2
20,GO_Biological_Process_2018,membrane assembly (GO:0071709),1/23,0.0227609834903901,0.0744904914230949,0,0,47.74641148325359,180.6107068727385,PTPRD
21,GO_Biological_Process_2018,metanephros development (GO:0001656),1/23,0.0227609834903901,0.0744904914230949,0,0,47.74641148325359,180.6107068727385,ROBO2
181,GO_Biological_Process_2017b,positive regulation of cytoskeleton organization (GO:0051495),1/25,0.0247167737784927,0.0787097262072389,0,0,43.76315789473684,161.93563879493826,LMAN1
180,GO_Biological_Process_2017b,neurexin clustering involved in presynaptic membrane assembly (GO:0097115),1/25,0.0247167737784927,0.0787097262072389,0,0,43.76315789473684,161.93563879493826,PTPRD
22,GO_Biological_Process_2018,positive regulation of synapse assembly (GO:0051965),1/26,0.0256932740553108,0.0800065366084375,0,0,42.01052631578948,153.82263569148483,PTPRD
23,GO_Biological_Process_2018,regulation of neurotransmitter secretion (GO:0046928),1/27,0.0266688455361458,0.0800065366084375,0,0,40.392712550607285,146.39366123411943,CPLX4
184,GO_Biological_Process_2017b,neuron development involved in amphid sensory organ development (GO:0003388),1/27,0.0266688455361458,0.0825224654326022,0,0,40.392712550607285,146.39366123411943,MYT1L
182,GO_Biological_Process_2017b,cardiac neuron development (GO:0060959),1/27,0.0266688455361458,0.0825224654326022,0,0,40.392712550607285,146.39366123411943,MYT1L
183,GO_Biological_Process_2017b,neuromast hair cell development (GO:0035675),1/27,0.0266688455361458,0.0825224654326022,0,0,40.392712550607285,146.39366123411943,MYT1L
185,GO_Biological_Process_2017b,neuron maturation (GO:0042551),1/28,0.0276434890482457,0.0847389196992953,0,0,38.89473684210526,139.56851455439977,MYT1L
186,GO_Biological_Process_2017b,inner ear receptor cell development (GO:0060119),1/29,0.0286172054274548,0.0861141594514237,0,0,37.50375939849624,133.2788782141628,MYT1L
187,GO_Biological_Process_2017b,positive regulation of dendrite morphogenesis (GO:0050775),1/29,0.0286172054274548,0.0861141594514237,0,0,37.50375939849624,133.2788782141628,PTPRD
189,GO_Biological_Process_2017b,cell morphogenesis involved in neuron differentiation (GO:0048667),1/30,0.0295899955032417,0.0866564154023507,0,0,36.2087114337568,127.46621354176987,MYT1L
188,GO_Biological_Process_2017b,photoreceptor cell development (GO:0042461),1/30,0.0295899955032417,0.0866564154023507,0,0,36.2087114337568,127.46621354176987,MYT1L
190,GO_Biological_Process_2017b,phenylalanine catabolic process to phosphoenolpyruvate (GO:0019562),1/30,0.0295899955032417,0.0866564154023507,0,0,36.2087114337568,127.46621354176987,PTPRD
191,GO_Biological_Process_2017b,peripheral nervous system neuron development (GO:0048935),1/31,0.0305618601074184,0.0866741766052342,0,0,35.0,122.08008572013848,MYT1L
192,GO_Biological_Process_2017b,positive regulation of intraciliary anterograde transport (GO:1905798),1/32,0.0315328000758389,0.0866741766052342,0,0,33.869269949066215,117.07681999296598,LMAN1
193,GO_Biological_Process_2017b,cellular response to gibberellin stimulus (GO:0071370),1/33,0.0325028162269628,0.0866741766052342,0,0,32.80921052631579,112.41841533087528,ROBO2
194,GO_Biological_Process_2017b,cellular response to abscisic acid stimulus (GO:0071215),1/33,0.0325028162269628,0.0866741766052342,0,0,32.80921052631579,112.41841533087528,ROBO2
196,GO_Biological_Process_2017b,cellular response to ethylene stimulus (GO:0071369),1/33,0.0325028162269628,0.0866741766052342,0,0,32.80921052631579,112.41841533087528,ROBO2
197,GO_Biological_Process_2017b,cellular response to auxin stimulus (GO:0071365),1/33,0.0325028162269628,0.0866741766052342,0,0,32.80921052631579,112.41841533087528,ROBO2
201,GO_Biological_Process_2017b,positive regulation of autophagosome maturation (GO:1901098),1/33,0.0325028162269628,0.0866741766052342,0,0,32.80921052631579,112.41841533087528,LMAN1
200,GO_Biological_Process_2017b,noradrenergic neuron development (GO:0003358),1/33,0.0325028162269628,0.0866741766052342,0,0,32.80921052631579,112.41841533087528,MYT1L
199,GO_Biological_Process_2017b,cellular response to cytokinin stimulus (GO:0071368),1/33,0.0325028162269628,0.0866741766052342,0,0,32.80921052631579,112.41841533087528,ROBO2
198,GO_Biological_Process_2017b,central nervous system neuron development (GO:0021954),1/33,0.0325028162269628,0.0866741766052342,0,0,32.80921052631579,112.41841533087528,MYT1L
195,GO_Biological_Process_2017b,positive regulation of intraciliary retrograde transport (GO:1905801),1/33,0.0325028162269628,0.0866741766052342,0,0,32.80921052631579,112.41841533087528,LMAN1
25,GO_Biological_Process_2018,positive regulation of organelle organization (GO:0010638),1/33,0.0325028162269628,0.089258425069603,0,0,32.80921052631579,112.41841533087528,LMAN1
26,GO_Biological_Process_2018,endoplasmic reticulum organization (GO:0007029),1/34,0.0334719094011011,0.089258425069603,0,0,31.8133971291866,108.07165990908112,LMAN1
24,GO_Biological_Process_2018,positive regulation of dendrite development (GO:1900006),1/32,0.0315328000758389,0.089258425069603,0,0,33.869269949066215,117.07681999296598,PTPRD
202,GO_Biological_Process_2017b,positive regulation of dendritic spine morphogenesis (GO:0061003),1/35,0.0344400804224879,0.0910995675691615,0,0,30.876160990712076,104.00740624656504,PTPRD
204,GO_Biological_Process_2017b,positive regulation of axon guidance (GO:1902669),1/36,0.0354073301248565,0.0921714625472455,0,0,29.99248120300752,100.19997336732251,ROBO2
203,GO_Biological_Process_2017b,cellular response to parathyroid hormone stimulus (GO:0071374),1/36,0.0354073301248565,0.0921714625472455,0,0,29.99248120300752,100.19997336732251,ROBO2
27,GO_Biological_Process_2018,positive regulation of axonogenesis (GO:0050772),1/37,0.0363736593292806,0.0935322668467216,0,0,29.157894736842103,96.62665093408292,ROBO2
205,GO_Biological_Process_2017b,cellular response to jasmonic acid stimulus (GO:0071395),1/37,0.0363736593292806,0.0939414193701105,0,0,29.157894736842103,96.62665093408292,ROBO2
206,GO_Biological_Process_2017b,cellular response to gonadotropin stimulus (GO:0071371),1/38,0.0373390688738262,0.0956813639891798,0,0,28.36842105263158,93.26728562261796,ROBO2
28,GO_Biological_Process_2018,regulation of cellular localization (GO:0060341),1/40,0.039267132268101,0.0974908111483887,0,0,26.910931174089068,87.12057233834933,CPLX4
207,GO_Biological_Process_2017b,cellular response to leptin stimulus (GO:0044320),1/40,0.039267132268101,0.0990739952610548,0,0,26.910931174089068,87.12057233834933,ROBO2
208,GO_Biological_Process_2017b,cellular response to hormone stimulus (GO:0032870),1/40,0.039267132268101,0.0990739952610548,0,0,26.910931174089068,87.12057233834933,ROBO2
31,GO_Biological_Process_2018,peptidyl-asparagine modification (GO:0018196),1/45,0.044071254437806,0.0991603224850635,0,0,23.84688995215311,74.44873932423765,LMAN1
30,GO_Biological_Process_2018,regulation of dendrite morphogenesis (GO:0048814),1/44,0.0431122594296053,0.0991603224850635,0,0,24.402692778457773,76.72079424655034,PTPRD
29,GO_Biological_Process_2018,protein N-linked glycosylation via asparagine (GO:0018279),1/44,0.0431122594296053,0.0991603224850635,0,0,24.402692778457773,76.72079424655034,LMAN1
32,GO_Biological_Process_2018,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),1/47,0.0459865060964822,0.1003341951195976,0,0,22.80778032036613,70.23444455974413,PTPRD
209,GO_Biological_Process_2017b,protein N-linked N-acetylglucosaminylation via asparagine (GO:0071903),1/42,0.0411915269172122,0.1008270211107883,0,0,25.59563543003851,81.63786025385905,LMAN1
211,GO_Biological_Process_2017b,cellular response to prostaglandin stimulus (GO:0071379),1/42,0.0411915269172122,0.1008270211107883,0,0,25.59563543003851,81.63786025385905,ROBO2
212,GO_Biological_Process_2017b,protein N-linked N-acetylgalactosaminylation via asparagine (GO:0071904),1/42,0.0411915269172122,0.1008270211107883,0,0,25.59563543003851,81.63786025385905,LMAN1
210,GO_Biological_Process_2017b,protein N-linked glucosylation via asparagine (GO:0071905),1/42,0.0411915269172122,0.1008270211107883,0,0,25.59563543003851,81.63786025385905,LMAN1
213,GO_Biological_Process_2017b,sucrose catabolic process via 3'-ketosucrose (GO:0019574),1/43,0.0421523505298068,0.1024145998057529,0,0,24.98496240601504,79.11400474395023,PTPRD
216,GO_Biological_Process_2017b,dephosphorylation (GO:0016311),1/44,0.0431122594296053,0.1024697180645692,0,0,24.402692778457773,76.72079424655034,PTPRD
215,GO_Biological_Process_2017b,cellular response to thyroid hormone stimulus (GO:0097067),1/44,0.0431122594296053,0.1024697180645692,0,0,24.402692778457773,76.72079424655034,ROBO2
214,GO_Biological_Process_2017b,central nervous system development (GO:0007417),2/333,0.0431097224990701,0.1024697180645692,0,0,6.595837529372273,20.737357564438184,ROBO2;MYT1L
217,GO_Biological_Process_2017b,cellular response to brassinosteroid stimulus (GO:0071367),1/45,0.044071254437806,0.1039954780978443,0,0,23.84688995215311,74.44873932423765,ROBO2
218,GO_Biological_Process_2017b,phosphorylation (GO:0016310),1/46,0.0450293363875485,0.1054973023936852,0,0,23.31578947368421,72.28923154104575,PTPRD
219,GO_Biological_Process_2017b,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),1/47,0.0459865060964822,0.1069757021251502,0,0,22.80778032036613,70.23444455974413,PTPRD
33,GO_Biological_Process_2018,positive regulation of nervous system development (GO:0051962),1/52,0.0507586997365511,0.1074890112068142,0,0,20.56656346749226,61.30218505418602,PTPRD
220,GO_Biological_Process_2017b,cellular response to peptide hormone stimulus (GO:0071375),1/48,0.0469427643840033,0.1084311740700921,0,0,22.32138857782755,68.27724816722397,ROBO2
39,GO_Biological_Process_2018,COPII vesicle coating (GO:0048208),1/63,0.0611778250716139,0.1090880988915015,0,0,16.908319185059423,47.24134484792992,LMAN1
38,GO_Biological_Process_2018,vesicle coating (GO:0006901),1/63,0.0611778250716139,0.1090880988915015,0,0,16.908319185059423,47.24134484792992,LMAN1
37,GO_Biological_Process_2018,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",1/63,0.0611778250716139,0.1090880988915015,0,0,16.908319185059423,47.24134484792992,LMAN1
34,GO_Biological_Process_2018,regulation of axonogenesis (GO:0050770),1/55,0.0536111215176,0.1090880988915015,0,0,19.42105263157895,56.82597555721978,ROBO2
35,GO_Biological_Process_2018,regulation of secretion by cell (GO:1903530),1/56,0.0545601179499192,0.1090880988915015,0,0,19.066985645933013,55.45541451142644,CPLX4
40,GO_Biological_Process_2018,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),1/64,0.0621196118687717,0.1090880988915015,0,0,16.639097744360903,46.23495322747936,ROBO2
36,GO_Biological_Process_2018,kidney development (GO:0001822),1/63,0.0611778250716139,0.1090880988915015,0,0,16.908319185059423,47.24134484792992,ROBO2
75,WikiPathways_2019_Human,Development and heterogeneity of the ILC family WP3893,1/32,0.0315328000758389,0.1129107989242708,0,0,33.869269949066215,117.07681999296598,TOX
76,WikiPathways_2019_Human,Complement and Coagulation Cascades WP558,1/58,0.0564553994621354,0.1129107989242708,0,0,18.39612188365651,52.87605301742885,LMAN1
41,GO_Biological_Process_2018,COPII-coated vesicle budding (GO:0090114),1/68,0.0658777916264093,0.1129333570738446,0,0,15.642576590730558,42.54708713186295,LMAN1
221,GO_Biological_Process_2017b,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),1/52,0.0507586997365511,0.1164255490460753,0,0,20.56656346749226,61.30218505418602,ROBO2
222,GO_Biological_Process_2017b,metanephros development (GO:0001656),1/53,0.051710413228189,0.1177848301308751,0,0,20.17004048582996,59.74559828701417,ROBO2
42,GO_Biological_Process_2018,protein N-linked glycosylation (GO:0006487),1/73,0.0705554002871621,0.1181392748994343,0,0,14.552631578947368,38.5842224505161,LMAN1
43,GO_Biological_Process_2018,nervous system development (GO:0007399),2/455,0.0749504020331541,0.1226461124178886,0,0,4.789551140544518,12.409385464317795,ROBO2;MYT1L
44,GO_Biological_Process_2018,cellular response to hormone stimulus (GO:0032870),1/80,0.077066682850071,0.1233066925601137,0,0,13.258494337108594,33.982637627801715,ROBO2
45,GO_Biological_Process_2018,modulation of chemical synaptic transmission (GO:0050804),1/82,0.0789190752282122,0.1235255090528539,0,0,12.929824561403509,32.8331213455501,CPLX4
224,GO_Biological_Process_2017b,positive regulation of vesicle fusion (GO:0031340),1/57,0.0555082103235644,0.1247033766173229,0,0,18.72556390977444,54.1398060702703,LMAN1
223,GO_Biological_Process_2017b,inositol phosphate metabolic process (GO:0043647),1/57,0.0555082103235644,0.1247033766173229,0,0,18.72556390977444,54.1398060702703,PTPRD
225,GO_Biological_Process_2017b,dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940),2/387,0.0564185021858079,0.1258861817479252,0,0,5.655122655122655,16.25824080449533,PTPRD;MYT1L
226,GO_Biological_Process_2017b,phospholipid metabolic process (GO:0006644),1/59,0.0574016861834188,0.1272145477578471,0,0,18.07803992740472,51.661282065881295,PTPRD
46,GO_Biological_Process_2018,positive regulation of cellular component biogenesis (GO:0044089),1/87,0.0835346163259223,0.1279679228822639,0,0,12.175030599755202,30.22444243789128,PTPRD
227,GO_Biological_Process_2017b,cellular response to steroid hormone stimulus (GO:0071383),1/61,0.0592915555925576,0.130521008284288,0,0,17.473684210526315,49.3681970360476,ROBO2
228,GO_Biological_Process_2017b,protein N-linked glycosylation via asparagine (GO:0018279),1/62,0.0602351399190365,0.1317141726229599,0,0,17.186367558239862,48.28508895429952,LMAN1
77,WikiPathways_2019_Human,Endoderm Differentiation WP2853,1/141,0.1320025081276732,0.1372349315735105,0,0,7.458646616541353,15.10326978018187,TOX
78,WikiPathways_2019_Human,Mesodermal Commitment Pathway WP2857,1/147,0.1372349315735105,0.1372349315735105,0,0,7.149963950973324,14.200264502888531,TOX
47,GO_Biological_Process_2018,positive regulation of neuron projection development (GO:0010976),1/97,0.0926998655948555,0.1390497983922833,0,0,10.901315789473683,25.92756145195716,ROBO2
230,GO_Biological_Process_2017b,Golgi inheritance (GO:0048313),1/68,0.0658777916264093,0.1421573398254097,0,0,15.642576590730558,42.54708713186295,LMAN1
229,GO_Biological_Process_2017b,Golgi organization (GO:0007030),1/68,0.0658777916264093,0.1421573398254097,0,0,15.642576590730558,42.54708713186295,LMAN1
231,GO_Biological_Process_2017b,Golgi distribution to daughter cells (GO:0090167),1/70,0.0677515123929905,0.1452450723196136,0,0,15.187643020594964,40.88374528633187,LMAN1
233,GO_Biological_Process_2017b,Golgi reassembly (GO:0090168),1/71,0.0686870333104677,0.1453506253279575,0,0,14.969924812030076,40.09237540517205,LMAN1
232,GO_Biological_Process_2017b,positive regulation of axonogenesis (GO:0050772),1/71,0.0686870333104677,0.1453506253279575,0,0,14.969924812030076,40.09237540517205,ROBO2
234,GO_Biological_Process_2017b,Golgi disassembly (GO:0090166),1/74,0.0714882479432861,0.1503086238807554,0,0,14.352559480894016,37.865241152955655,LMAN1
235,GO_Biological_Process_2017b,Golgi ribbon formation (GO:0090161),1/76,0.0733512756104792,0.1532434293008737,0,0,13.968421052631578,36.49243551909278,LMAN1
48,GO_Biological_Process_2018,regulation of organelle organization (GO:0033043),1/113,0.1071833849179316,0.1543439053966524,0,0,9.336466165413531,20.8503272666542,LMAN1
53,GO_Biological_Process_2018,dephosphorylation (GO:0016311),1/124,0.1170131002125961,0.1543439053966524,0,0,8.496790757381259,18.22960442221716,PTPRD
52,GO_Biological_Process_2018,Golgi organization (GO:0007030),1/121,0.1143425137021189,0.1543439053966524,0,0,8.710526315789474,18.889271325741056,LMAN1
54,GO_Biological_Process_2018,protein dephosphorylation (GO:0006470),1/125,0.1179015944002206,0.1543439053966524,0,0,8.427843803056026,18.01792896923992,PTPRD
51,GO_Biological_Process_2018,enzyme linked receptor protein signaling pathway (GO:0007167),1/120,0.1134506143347115,0.1543439053966524,0,0,8.784166298098187,19.117751070838278,PTPRD
50,GO_Biological_Process_2018,brain development (GO:0007420),1/119,0.1125578617216778,0.1543439053966524,0,0,8.859054415700268,19.350725039139657,ROBO2
49,GO_Biological_Process_2018,chromatin remodeling (GO:0006338),1/116,0.1098744767967273,0.1543439053966524,0,0,9.091533180778033,20.077893566776314,TOX
55,GO_Biological_Process_2018,cellular response to organic substance (GO:0071310),1/133,0.1249790349715015,0.1606873306776449,0,0,7.913875598086125,16.457769102687624,ROBO2
237,GO_Biological_Process_2017b,peptidyl-N-phospho-arginine dephosphorylation (GO:0098628),1/83,0.0798439464103719,0.1636800901412625,0,0,12.771501925545572,32.28228555834262,PTPRD
236,GO_Biological_Process_2017b,positive regulation of collateral sprouting (GO:0048672),1/82,0.0789190752282122,0.1636800901412625,0,0,12.929824561403509,32.8331213455501,ROBO2
238,GO_Biological_Process_2017b,peptidyl-histidine dephosphorylation (GO:0035971),1/83,0.0798439464103719,0.1636800901412625,0,0,12.771501925545572,32.28228555834262,PTPRD
239,GO_Biological_Process_2017b,regulation of translational initiation by eIF2 alpha dephosphorylation (GO:0036496),1/84,0.0807679353123666,0.1643844295391082,0,0,12.61699429296132,31.74656854741361,PTPRD
240,GO_Biological_Process_2017b,brain segmentation (GO:0035284),1/85,0.0816910427282763,0.1643844295391082,0,0,12.466165413533837,31.225387249064404,ROBO2
241,GO_Biological_Process_2017b,trigeminal sensory nucleus development (GO:0021730),1/85,0.0816910427282763,0.1643844295391082,0,0,12.466165413533837,31.225387249064404,ROBO2
73,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.1527530095103514,0.1663239190403913,0,0,6.359435173299102,11.948952474473325,LMAN1
72,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0752107517706809,0.1663239190403913,0,0,13.604237867395762,35.20043603994484,CPLX4
74,KEGG_2019_Human,Axon guidance,1/181,0.1663239190403913,0.1663239190403913,0,0,5.789473684210527,10.385262524745686,ROBO2
242,GO_Biological_Process_2017b,ventricular system development (GO:0021591),1/87,0.0835346163259223,0.1670692326518446,0,0,12.175030599755202,30.22444243789128,ROBO2
243,GO_Biological_Process_2017b,peptidyl-serine dephosphorylation (GO:0070262),1/88,0.0844550840845328,0.1678864701801622,0,0,12.03448275862069,29.7436505826784,PTPRD
244,GO_Biological_Process_2017b,peptidyl-threonine dephosphorylation (GO:0035970),1/89,0.0853746735440269,0.1686921260388002,0,0,11.897129186602871,29.27533461302574,PTPRD
56,GO_Biological_Process_2018,neuron development (GO:0048666),1/144,0.1346224767664678,0.1700494443365909,0,0,7.301067353698933,14.640690814421308,MYT1L
245,GO_Biological_Process_2017b,histone dephosphorylation (GO:0016576),1/92,0.0881281800641533,0.1730900782098342,0,0,11.50318102949682,27.94080032839929,PTPRD
246,GO_Biological_Process_2017b,brain morphogenesis (GO:0048854),1/94,0.0899594741237405,0.1732942431608212,0,0,11.254668930390492,27.10569960599241,ROBO2
248,GO_Biological_Process_2017b,central nervous system segmentation (GO:0035283),1/95,0.0908738104379916,0.1732942431608212,0,0,11.13437849944009,26.70339549535462,ROBO2
249,GO_Biological_Process_2017b,ventral cord development (GO:0007419),1/95,0.0908738104379916,0.1732942431608212,0,0,11.13437849944009,26.70339549535462,ROBO2
250,GO_Biological_Process_2017b,central nervous system maturation (GO:0021626),1/95,0.0908738104379916,0.1732942431608212,0,0,11.13437849944009,26.70339549535462,ROBO2
247,GO_Biological_Process_2017b,larval central nervous system remodeling (GO:0035193),1/95,0.0908738104379916,0.1732942431608212,0,0,11.13437849944009,26.70339549535462,ROBO2
251,GO_Biological_Process_2017b,preganglionic parasympathetic fiber development (GO:0021783),1/96,0.0917872740073591,0.174024427019733,0,0,11.01662049861496,26.310792233027552,ROBO2
252,GO_Biological_Process_2017b,peptidyl-tyrosine dephosphorylation (GO:0035335),1/97,0.0926998655948555,0.1747445742247852,0,0,10.901315789473683,25.92756145195716,PTPRD
253,GO_Biological_Process_2017b,neuron projection development (GO:0031175),1/99,0.0945224360353158,0.1771620515404777,0,0,10.677765843179378,25.18797462704863,MYT1L
254,GO_Biological_Process_2017b,positive regulation of axon extension (GO:0045773),1/100,0.0954324164624814,0.17785132158917,0,0,10.569377990430622,24.83103038927071,ROBO2
255,GO_Biological_Process_2017b,astrocyte differentiation (GO:0048708),1/103,0.0981571479706876,0.1815244679685868,0,0,10.256965944272446,23.808320971600697,ROBO2
257,GO_Biological_Process_2017b,spinal cord development (GO:0021510),1/104,0.0990636578243202,0.1815244679685868,0,0,10.15687276443536,23.4826149464007,ROBO2
256,GO_Biological_Process_2017b,oligodendrocyte differentiation (GO:0048709),1/104,0.0990636578243202,0.1815244679685868,0,0,10.15687276443536,23.4826149464007,ROBO2
57,GO_Biological_Process_2018,axon guidance (GO:0007411),1/158,0.1467499768501904,0.1821723850554087,0,0,6.645323499832384,12.752541783227706,ROBO2
258,GO_Biological_Process_2017b,microglia differentiation (GO:0014004),1/110,0.1044845651566293,0.1903940965076357,0,0,9.594881699662,21.67211204877382,ROBO2
259,GO_Biological_Process_2017b,establishment of endothelial blood-brain barrier (GO:0014045),1/112,0.1062846380154363,0.1926042059064261,0,0,9.421052631578949,21.11855678854484,ROBO2
266,GO_Biological_Process_2017b,corticospinal neuron axon guidance through spinal cord (GO:0021972),1/128,0.1205619837822294,0.1976585199674989,0,0,8.227517612929963,17.406064436257147,ROBO2
281,GO_Biological_Process_2017b,retinal ganglion cell axon guidance (GO:0031290),1/130,0.1223313401018362,0.1976585199674989,0,0,8.099143206854345,17.016478165448806,ROBO2
268,GO_Biological_Process_2017b,olfactory bulb axon guidance (GO:0071678),1/128,0.1205619837822294,0.1976585199674989,0,0,8.227517612929963,17.406064436257147,ROBO2
269,GO_Biological_Process_2017b,photoreceptor cell axon guidance (GO:0072499),1/128,0.1205619837822294,0.1976585199674989,0,0,8.227517612929963,17.406064436257147,ROBO2
270,GO_Biological_Process_2017b,dopaminergic neuron axon guidance (GO:0036514),1/128,0.1205619837822294,0.1976585199674989,0,0,8.227517612929963,17.406064436257147,ROBO2
271,GO_Biological_Process_2017b,corticospinal neuron axon guidance through the medullary pyramid (GO:0021971),1/128,0.1205619837822294,0.1976585199674989,0,0,8.227517612929963,17.406064436257147,ROBO2
272,GO_Biological_Process_2017b,semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287),1/128,0.1205619837822294,0.1976585199674989,0,0,8.227517612929963,17.406064436257147,ROBO2
273,GO_Biological_Process_2017b,axon choice point recognition (GO:0016198),1/128,0.1205619837822294,0.1976585199674989,0,0,8.227517612929963,17.406064436257147,ROBO2
274,GO_Biological_Process_2017b,corticospinal neuron axon guidance through the basilar pons (GO:0021970),1/128,0.1205619837822294,0.1976585199674989,0,0,8.227517612929963,17.406064436257147,ROBO2
275,GO_Biological_Process_2017b,dorsal/ventral axon guidance (GO:0033563),1/128,0.1205619837822294,0.1976585199674989,0,0,8.227517612929963,17.406064436257147,ROBO2
276,GO_Biological_Process_2017b,corticospinal neuron axon guidance through the cerebral cortex (GO:0021967),1/128,0.1205619837822294,0.1976585199674989,0,0,8.227517612929963,17.406064436257147,ROBO2
277,GO_Biological_Process_2017b,VEGF-activated neuropilin signaling pathway involved in axon guidance (GO:1902378),1/129,0.1214470850948444,0.1976585199674989,0,0,8.162828947368421,17.209501461061883,ROBO2
267,GO_Biological_Process_2017b,sympathetic neuron axon guidance (GO:0097492),1/128,0.1205619837822294,0.1976585199674989,0,0,8.227517612929963,17.406064436257147,ROBO2
278,GO_Biological_Process_2017b,corticospinal neuron axon guidance (GO:0021966),1/129,0.1214470850948444,0.1976585199674989,0,0,8.162828947368421,17.209501461061883,ROBO2
280,GO_Biological_Process_2017b,commissural neuron axon guidance (GO:0071679),1/130,0.1223313401018362,0.1976585199674989,0,0,8.099143206854345,17.016478165448806,ROBO2
265,GO_Biological_Process_2017b,anterior/posterior axon guidance (GO:0033564),1/128,0.1205619837822294,0.1976585199674989,0,0,8.227517612929963,17.406064436257147,ROBO2
264,GO_Biological_Process_2017b,interneuron axon guidance (GO:0097376),1/128,0.1205619837822294,0.1976585199674989,0,0,8.227517612929963,17.406064436257147,ROBO2
279,GO_Biological_Process_2017b,Roundabout signaling pathway involved in axon guidance (GO:2001266),1/130,0.1223313401018362,0.1976585199674989,0,0,8.099143206854345,17.016478165448806,ROBO2
262,GO_Biological_Process_2017b,corticospinal neuron axon guidance through the cerebral peduncle (GO:0021969),1/128,0.1205619837822294,0.1976585199674989,0,0,8.227517612929963,17.406064436257147,ROBO2
261,GO_Biological_Process_2017b,corticospinal neuron axon guidance through the internal capsule (GO:0021968),1/128,0.1205619837822294,0.1976585199674989,0,0,8.227517612929963,17.406064436257147,ROBO2
260,GO_Biological_Process_2017b,serotonergic neuron axon guidance (GO:0036515),1/128,0.1205619837822294,0.1976585199674989,0,0,8.227517612929963,17.406064436257147,ROBO2
263,GO_Biological_Process_2017b,sensory neuron axon guidance (GO:0097374),1/128,0.1205619837822294,0.1976585199674989,0,0,8.227517612929963,17.406064436257147,ROBO2
282,GO_Biological_Process_2017b,motor neuron axon guidance (GO:0008045),1/133,0.1249790349715015,0.2009466836796692,0,0,7.913875598086125,16.457769102687624,ROBO2
283,GO_Biological_Process_2017b,chemorepulsion of axon (GO:0061643),1/134,0.1258599124312047,0.2013758598899276,0,0,7.853977047882865,16.27804127663435,ROBO2
59,GO_Biological_Process_2018,phosphate-containing compound metabolic process (GO:0006796),1/183,0.1680056895810476,0.2016068274972572,0,0,5.725274725274725,10.212501350602295,PTPRD
58,GO_Biological_Process_2018,ER to Golgi vesicle-mediated transport (GO:0006888),1/180,0.1654818231902095,0.2016068274972572,0,0,5.822111143781241,10.473360337315544,LMAN1
60,GO_Biological_Process_2018,protein complex assembly (GO:0006461),1/189,0.1730316847300859,0.2042341196814129,0,0,5.5408734602463605,9.720246555313304,LMAN1
284,GO_Biological_Process_2017b,axon extension involved in axon guidance (GO:0048846),1/139,0.130251677909176,0.2073910211369405,0,0,7.567505720823799,15.424746385609486,ROBO2
285,GO_Biological_Process_2017b,chemoattraction of axon (GO:0061642),1/142,0.1328766671456546,0.2105485353805541,0,0,7.405375139977604,14.946519655220376,ROBO2
287,GO_Biological_Process_2017b,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",1/146,0.1363649469064392,0.214008146341206,0,0,7.199637023593467,14.34470478778898,LMAN1
286,GO_Biological_Process_2017b,endoplasmic reticulum-Golgi intermediate compartment (ERGIC) derived vesicle fusion with Golgi cis cisterna membrane (GO:1990689),1/146,0.1363649469064392,0.214008146341206,0,0,7.199637023593467,14.34470478778898,LMAN1
288,GO_Biological_Process_2017b,COPII vesicle uncoating (GO:0090112),1/147,0.1372349315735105,0.2143478931243403,0,0,7.149963950973324,14.200264502888531,LMAN1
289,GO_Biological_Process_2017b,COPII-coated vesicle budding (GO:0090114),1/150,0.1398398929473613,0.217381444960827,0,0,7.004945249028612,13.78052850470674,LMAN1
290,GO_Biological_Process_2017b,endoplasmic reticulum-derived vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane (GO:1990687),1/151,0.1407065517297098,0.2176969290912491,0,0,6.957894736842105,13.64497951804777,LMAN1
291,GO_Biological_Process_2017b,ER to Golgi vesicle-mediated transport (GO:0006888),1/152,0.1415723809153899,0.2180081734283938,0,0,6.911467410247473,13.511532897552032,LMAN1
61,GO_Biological_Process_2018,central nervous system development (GO:0007417),1/217,0.1961073669325375,0.2277375874055275,0,0,4.815789473684211,7.8453688211824035,ROBO2
62,GO_Biological_Process_2018,axonogenesis (GO:0007409),1/223,0.200971928799267,0.2296822043420194,0,0,4.684210526315789,7.516237548253504,ROBO2
292,GO_Biological_Process_2017b,COPII vesicle coating (GO:0048208),1/168,0.1553134362304271,0.2380505003905612,0,0,6.244248345414435,11.628726352614157,LMAN1
293,GO_Biological_Process_2017b,brain development (GO:0007420),1/174,0.1604122537407113,0.2447219498928061,0,0,6.02585944630362,11.027372148017925,ROBO2
294,GO_Biological_Process_2017b,axon guidance (GO:0007411),1/182,0.1671652076003928,0.2538434633931891,0,0,5.757196859552195,10.298316504681203,ROBO2
295,GO_Biological_Process_2017b,protein dephosphorylation (GO:0006470),1/186,0.1705223035059393,0.2577479979260281,0,0,5.631578947368421,9.961639057655574,PTPRD
63,GO_Biological_Process_2018,Golgi vesicle transport (GO:0048193),1/271,0.2388940895616739,0.2687558507568832,0,0,3.842105263157895,5.500876445147768,LMAN1
296,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in neuron differentiation (GO:1904081),2/770,0.1787319702679617,0.2689178268251901,0,0,2.779513888888889,4.78595593224767,PTPRD;MYT1L
297,GO_Biological_Process_2017b,planar cell polarity pathway involved in axon guidance (GO:1904938),1/213,0.1928487092831233,0.2888327700678741,0,0,4.907646474677259,8.077246452197812,ROBO2
353,GO_Biological_Process_2017b,regulation of transcription involved in anterior/posterior axis specification (GO:0044324),1/311,0.2691835059061246,0.3210625088625777,0,0,3.33955857385399,4.382709615040727,MYT1L
334,GO_Biological_Process_2017b,regulation of nodal signaling pathway involved in determination of left/right asymmetry (GO:1900145),1/301,0.2617203673439697,0.3210625088625777,0,0,3.4526315789473685,4.6281789020311335,MYT1L
333,GO_Biological_Process_2017b,regulation of snRNA transcription from RNA polymerase II promoter (GO:1905380),1/301,0.2617203673439697,0.3210625088625777,0,0,3.4526315789473685,4.6281789020311335,MYT1L
332,GO_Biological_Process_2017b,positive regulation of mating type switching by regulation of transcription from RNA polymerase II promoter (GO:1900374),1/301,0.2617203673439697,0.3210625088625777,0,0,3.4526315789473685,4.6281789020311335,MYT1L
331,GO_Biological_Process_2017b,regulation of transcription from RNA polymerase II promoter involved in mammary gland formation (GO:0060597),1/301,0.2617203673439697,0.3210625088625777,0,0,3.4526315789473685,4.6281789020311335,MYT1L
346,GO_Biological_Process_2017b,regulation of transcription involved in cell fate commitment (GO:0060850),1/306,0.2654609411363627,0.3210625088625777,0,0,3.395168248490078,4.50296942391665,MYT1L
330,GO_Biological_Process_2017b,regulation of phenotypic switching by regulation of transcription from RNA polymerase II promoter (GO:1900545),1/301,0.2617203673439697,0.3210625088625777,0,0,3.4526315789473685,4.6281789020311335,MYT1L
329,GO_Biological_Process_2017b,regulation of transcription from RNA polymerase II promoter involved in spinal cord anterior-posterior patterning (GO:0021909),1/301,0.2617203673439697,0.3210625088625777,0,0,3.4526315789473685,4.6281789020311335,MYT1L
328,GO_Biological_Process_2017b,regulation of ergosterol biosynthetic process by regulation of transcription from RNA polymerase II promoter (GO:0035960),1/301,0.2617203673439697,0.3210625088625777,0,0,3.4526315789473685,4.6281789020311335,MYT1L
327,GO_Biological_Process_2017b,regulation of oligopeptide transport by regulation of transcription from RNA polymerase II promoter (GO:0035950),1/301,0.2617203673439697,0.3210625088625777,0,0,3.4526315789473685,4.6281789020311335,MYT1L
326,GO_Biological_Process_2017b,regulation of pyrimidine nucleotide biosynthetic process by positive regulation of transcription from RNA polymerase II promoter (GO:1900448),1/301,0.2617203673439697,0.3210625088625777,0,0,3.4526315789473685,4.6281789020311335,MYT1L
325,GO_Biological_Process_2017b,regulation of fungal-type cell wall biogenesis by regulation of transcription from RNA polymerase II promoter (GO:1900415),1/301,0.2617203673439697,0.3210625088625777,0,0,3.4526315789473685,4.6281789020311335,MYT1L
324,GO_Biological_Process_2017b,regulation of transcription from RNA polymerase II promoter in response to methionine (GO:0061432),1/301,0.2617203673439697,0.3210625088625777,0,0,3.4526315789473685,4.6281789020311335,MYT1L
336,GO_Biological_Process_2017b,regulation of transcription involved in anterior neural plate formation (GO:0090019),1/301,0.2617203673439697,0.3210625088625777,0,0,3.4526315789473685,4.6281789020311335,MYT1L
337,GO_Biological_Process_2017b,regulation of carbohydrate metabolic process by regulation of transcription from RNA polymerase II promoter (GO:1900402),1/302,0.262469926784462,0.3210625088625777,0,0,3.440986186396223,4.602727703848208,MYT1L
340,GO_Biological_Process_2017b,regulation of cellular response to oxidative stress by regulation of transcription from RNA polymerase II promoter (GO:1900427),1/303,0.2632187632222048,0.3210625088625777,0,0,3.429417915650052,4.577483442184301,MYT1L
339,GO_Biological_Process_2017b,regulation of lipid transport by regulation of transcription from RNA polymerase II promoter (GO:0072367),1/303,0.2632187632222048,0.3210625088625777,0,0,3.429417915650052,4.577483442184301,MYT1L
345,GO_Biological_Process_2017b,regulation of transcription from RNA polymerase II promoter in response to iron (GO:0034395),1/306,0.2654609411363627,0.3210625088625777,0,0,3.395168248490078,4.50296942391665,MYT1L
341,GO_Biological_Process_2017b,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),1/303,0.2632187632222048,0.3210625088625777,0,0,3.429417915650052,4.577483442184301,MYT1L
342,GO_Biological_Process_2017b,regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter (GO:0072364),1/303,0.2632187632222048,0.3210625088625777,0,0,3.429417915650052,4.577483442184301,MYT1L
343,GO_Biological_Process_2017b,regulation of glucose import by regulation of transcription from RNA polymerase II promoter (GO:1900389),1/304,0.2639668773156942,0.3210625088625777,0,0,3.4179260031266283,4.55244381552359,MYT1L
344,GO_Biological_Process_2017b,regulation of cAMP-mediated signaling by regulation of transcription from RNA polymerase II promoter (GO:1900391),1/305,0.264714269716701,0.3210625088625777,0,0,3.406509695290859,4.5276065551872895,MYT1L
323,GO_Biological_Process_2017b,carbon catabolite regulation of transcription from RNA polymerase II promoter (GO:0000429),1/301,0.2617203673439697,0.3210625088625777,0,0,3.4526315789473685,4.6281789020311335,MYT1L
352,GO_Biological_Process_2017b,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),1/311,0.2691835059061246,0.3210625088625777,0,0,3.33955857385399,4.382709615040727,MYT1L
351,GO_Biological_Process_2017b,regulation of transcription from RNA polymerase II promoter in response to copper ion (GO:0061396),1/309,0.2676966358049682,0.3210625088625777,0,0,3.3615857826384143,4.430236913470875,MYT1L
350,GO_Biological_Process_2017b,regulation of BMP signaling pathway (GO:0030510),1/309,0.2676966358049682,0.3210625088625777,0,0,3.3615857826384143,4.430236913470875,MYT1L
349,GO_Biological_Process_2017b,regulation of androgen receptor activity (GO:2000823),1/309,0.2676966358049682,0.3210625088625777,0,0,3.3615857826384143,4.430236913470875,MYT1L
348,GO_Biological_Process_2017b,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),1/308,0.2669521234886096,0.3210625088625777,0,0,3.3727070118292475,4.454286762090836,MYT1L
347,GO_Biological_Process_2017b,regulation of transcription from RNA polymerase II promoter by histone modification (GO:1903756),1/306,0.2654609411363627,0.3210625088625777,0,0,3.395168248490078,4.50296942391665,MYT1L
338,GO_Biological_Process_2017b,regulation of replicative cell aging by regulation of transcription from RNA polymerase II promoter in response to caloric restriction (GO:0061434),1/303,0.2632187632222048,0.3210625088625777,0,0,3.429417915650052,4.577483442184301,MYT1L
322,GO_Biological_Process_2017b,regulation of mating-type specific transcription from RNA polymerase II promoter (GO:0001196),1/301,0.2617203673439697,0.3210625088625777,0,0,3.4526315789473685,4.6281789020311335,MYT1L
335,GO_Biological_Process_2017b,positive regulation of phenotypic switching by regulation of transcription from RNA polymerase II promoter (GO:1900546),1/301,0.2617203673439697,0.3210625088625777,0,0,3.4526315789473685,4.6281789020311335,MYT1L
320,GO_Biological_Process_2017b,regulation of thyroid hormone receptor activity (GO:1904167),1/301,0.2617203673439697,0.3210625088625777,0,0,3.4526315789473685,4.6281789020311335,MYT1L
298,GO_Biological_Process_2017b,stomatogastric nervous system development (GO:0007421),1/244,0.2177786037292636,0.3210625088625777,0,0,4.274853801169591,6.516058384105807,MYT1L
299,GO_Biological_Process_2017b,ganglion development (GO:0061548),1/244,0.2177786037292636,0.3210625088625777,0,0,4.274853801169591,6.516058384105807,MYT1L
301,GO_Biological_Process_2017b,autonomic nervous system development (GO:0048483),1/245,0.2185704849775349,0.3210625088625777,0,0,4.257118205349439,6.473572881408745,MYT1L
302,GO_Biological_Process_2017b,peripheral nervous system development (GO:0007422),1/255,0.226447522853766,0.3210625088625777,0,0,4.087443016991297,6.070842237976708,MYT1L
303,GO_Biological_Process_2017b,neural tube development (GO:0021915),1/259,0.2295771676714695,0.3210625088625777,0,0,4.023255813953488,5.920285557485273,MYT1L
304,GO_Biological_Process_2017b,determination of left/right asymmetry in nervous system (GO:0035545),1/270,0.2381217863295401,0.3210625088625777,0,0,3.856583838779104,5.53409379242142,MYT1L
305,GO_Biological_Process_2017b,neurogenesis (GO:0022008),1/272,0.2396656490013005,0.3210625088625777,0,0,3.8277335404933,5.467957385790095,MYT1L
306,GO_Biological_Process_2017b,synapse assembly (GO:0007416),1/285,0.2496285472815002,0.3210625088625777,0,0,3.650111193476649,5.065555972929943,MYT1L
307,GO_Biological_Process_2017b,regulation of transcription from RNA polymerase II promoter involved in lung bud formation (GO:0060500),1/301,0.2617203673439697,0.3210625088625777,0,0,3.4526315789473685,4.6281789020311335,MYT1L
308,GO_Biological_Process_2017b,regulation of iron ion transport by regulation of transcription from RNA polymerase II promoter (GO:1900393),1/301,0.2617203673439697,0.3210625088625777,0,0,3.4526315789473685,4.6281789020311335,MYT1L
300,GO_Biological_Process_2017b,nervous system development (GO:0007399),1/244,0.2177786037292636,0.3210625088625777,0,0,4.274853801169591,6.516058384105807,MYT1L
310,GO_Biological_Process_2017b,regulation of transcription involved in posterior neural plate formation (GO:0090020),1/301,0.2617203673439697,0.3210625088625777,0,0,3.4526315789473685,4.6281789020311335,MYT1L
309,GO_Biological_Process_2017b,regulation of thiamine biosynthetic process by regulation of transcription from RNA polymerase II promoter (GO:1900382),1/301,0.2617203673439697,0.3210625088625777,0,0,3.4526315789473685,4.6281789020311335,MYT1L
319,GO_Biological_Process_2017b,regulation of telomeric RNA transcription from RNA pol II promoter (GO:1901580),1/301,0.2617203673439697,0.3210625088625777,0,0,3.4526315789473685,4.6281789020311335,MYT1L
318,GO_Biological_Process_2017b,regulation of transcription from RNA polymerase II promoter during mitotic cell cycle (GO:0046021),1/301,0.2617203673439697,0.3210625088625777,0,0,3.4526315789473685,4.6281789020311335,MYT1L
317,GO_Biological_Process_2017b,nitrogen catabolite regulation of transcription from RNA polymerase II promoter (GO:0001079),1/301,0.2617203673439697,0.3210625088625777,0,0,3.4526315789473685,4.6281789020311335,MYT1L
316,GO_Biological_Process_2017b,negative regulation of leucine import by regulation of transcription from RNA polymerase II promoter (GO:1902574),1/301,0.2617203673439697,0.3210625088625777,0,0,3.4526315789473685,4.6281789020311335,MYT1L
321,GO_Biological_Process_2017b,regulation of termination of RNA polymerase II transcription (GO:1904594),1/301,0.2617203673439697,0.3210625088625777,0,0,3.4526315789473685,4.6281789020311335,MYT1L
314,GO_Biological_Process_2017b,regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902893),1/301,0.2617203673439697,0.3210625088625777,0,0,3.4526315789473685,4.6281789020311335,MYT1L
313,GO_Biological_Process_2017b,regulation of transcription from RNA polymerase II promoter involved in somitogenesis (GO:0090236),1/301,0.2617203673439697,0.3210625088625777,0,0,3.4526315789473685,4.6281789020311335,MYT1L
312,GO_Biological_Process_2017b,regulation of ribosomal protein gene transcription from RNA polymerase II promoter (GO:0060962),1/301,0.2617203673439697,0.3210625088625777,0,0,3.4526315789473685,4.6281789020311335,MYT1L
311,GO_Biological_Process_2017b,regulation of transcription from RNA polymerase II promoter by pheromones (GO:0046019),1/301,0.2617203673439697,0.3210625088625777,0,0,3.4526315789473685,4.6281789020311335,MYT1L
315,GO_Biological_Process_2017b,regulation of conjugation with cellular fusion by regulation of transcription from RNA polymerase II promoter (GO:1900406),1/301,0.2617203673439697,0.3210625088625777,0,0,3.4526315789473685,4.6281789020311335,MYT1L
354,GO_Biological_Process_2017b,regulation of SREBP signaling pathway (GO:2000638),1/318,0.2743649978381094,0.3260569539525358,0,0,3.264652166694338,4.22216142588564,MYT1L
355,GO_Biological_Process_2017b,regulation of phosphorylation of RNA polymerase II C-terminal domain (GO:1901407),1/322,0.2773101610873619,0.3283672665583202,0,0,3.2233152975897688,4.134284425406205,MYT1L
356,GO_Biological_Process_2017b,regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry (GO:1900094),1/324,0.2787784807885225,0.3289184953188323,0,0,3.203030796806257,4.091352273512236,MYT1L
357,GO_Biological_Process_2017b,regulation of transcription from RNA polymerase II promoter by calcium-mediated signaling (GO:1900621),1/338,0.2889776456196111,0.339729991982912,0,0,3.067780727783852,3.8083612323800375,MYT1L
358,GO_Biological_Process_2017b,regulation of transcription from RNA polymerase II promoter involved in kidney development (GO:0060994),1/340,0.2904234349232831,0.3402103094815602,0,0,3.049371215649744,3.770289227981902,MYT1L
359,GO_Biological_Process_2017b,torso signaling pathway (GO:0008293),1/371,0.3124791360451185,0.3647443296185013,0,0,2.789473684210526,3.244764819188342,MYT1L
360,GO_Biological_Process_2017b,regulation of transcription from RNA polymerase II promoter involved in heart development (GO:1901213),1/378,0.3173685181247582,0.3691378508685131,0,0,2.7367024989529525,3.140890640959947,MYT1L
361,GO_Biological_Process_2017b,BMP signaling pathway (GO:0030509),1/381,0.3194538394860498,0.3702503864007926,0,0,2.714681440443213,3.097838346524308,MYT1L
385,GO_Biological_Process_2017b,negative regulation of snRNA transcription from RNA polymerase II promoter (GO:1905381),1/481,0.3856016558621654,0.3997454590017084,0,0,2.138157894736842,2.037558468106244,MYT1L
386,GO_Biological_Process_2017b,negative regulation of inositol biosynthetic process by negative regulation of transcription from RNA polymerase II promoter (GO:1900471),1/482,0.3862311934886067,0.3997454590017084,0,0,2.133603238866397,2.02973760246591,MYT1L
384,GO_Biological_Process_2017b,negative regulation of mating type switching by negative regulation of transcription from RNA polymerase II promoter (GO:1900474),1/481,0.3856016558621654,0.3997454590017084,0,0,2.138157894736842,2.037558468106244,MYT1L
383,GO_Biological_Process_2017b,negative regulation of invasive growth in response to glucose limitation by negative regulation of transcription from RNA polymerase II promoter (GO:1900460),1/481,0.3856016558621654,0.3997454590017084,0,0,2.138157894736842,2.037558468106244,MYT1L
381,GO_Biological_Process_2017b,negative regulation of oligopeptide transport by negative regulation of transcription from RNA polymerase II promoter (GO:0035952),1/481,0.3856016558621654,0.3997454590017084,0,0,2.138157894736842,2.037558468106244,MYT1L
380,GO_Biological_Process_2017b,transfer RNA gene-mediated silencing (GO:0061587),1/481,0.3856016558621654,0.3997454590017084,0,0,2.138157894736842,2.037558468106244,MYT1L
379,GO_Biological_Process_2017b,negative regulation of phosphatidylcholine biosynthetic process by negative regulation of transcription from RNA polymerase II promoter (GO:1900473),1/481,0.3856016558621654,0.3997454590017084,0,0,2.138157894736842,2.037558468106244,MYT1L
387,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter during mitotic cell cycle (GO:0007070),1/482,0.3862311934886067,0.3997454590017084,0,0,2.133603238866397,2.02973760246591,MYT1L
382,GO_Biological_Process_2017b,negative regulation of induction of conjugation with cellular fusion by negative regulation of transcription from RNA polymerase II promoter (GO:1902625),1/481,0.3856016558621654,0.3997454590017084,0,0,2.138157894736842,2.037558468106244,MYT1L
395,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation (GO:2000820),1/484,0.387488430877893,0.3997454590017084,0,0,2.1245505067015364,2.0142210828802747,MYT1L
389,GO_Biological_Process_2017b,negative regulation of telomeric RNA transcription from RNA pol II promoter (GO:1901581),1/482,0.3862311934886067,0.3997454590017084,0,0,2.133603238866397,2.02973760246591,MYT1L
390,GO_Biological_Process_2017b,negative regulation of mitochondrial unfolded protein response by negative regulation of transcription from RNA polymerase II promoter (GO:1904490),1/483,0.3868601183294989,0.3997454590017084,0,0,2.1290674819829656,2.021958573619618,MYT1L
391,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage (GO:0010768),1/484,0.387488430877893,0.3997454590017084,0,0,2.1245505067015364,2.0142210828802747,MYT1L
392,GO_Biological_Process_2017b,positive regulation of gluconeogenesis by negative regulation of transcription from RNA polymerase II promoter (GO:0035949),1/484,0.387488430877893,0.3997454590017084,0,0,2.1245505067015364,2.0142210828802747,MYT1L
393,GO_Biological_Process_2017b,negative regulation of transcription initiation from RNA polymerase II promoter (GO:0060633),1/484,0.387488430877893,0.3997454590017084,0,0,2.1245505067015364,2.0142210828802747,MYT1L
394,GO_Biological_Process_2017b,negative regulation of ceramide biosynthetic process by negative regulation of transcription from RNA Polymerase II promoter (GO:0061427),1/484,0.387488430877893,0.3997454590017084,0,0,2.1245505067015364,2.0142210828802747,MYT1L
378,GO_Biological_Process_2017b,carbon catabolite repression of transcription from RNA polymerase II promoter (GO:0000437),1/481,0.3856016558621654,0.3997454590017084,0,0,2.138157894736842,2.037558468106244,MYT1L
396,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),1/485,0.3881161317057716,0.3997454590017084,0,0,2.120052196607221,2.006524833834278,MYT1L
397,GO_Biological_Process_2017b,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),1/487,0.3893697006246279,0.3997454590017084,0,0,2.111111111111111,1.9912548878034344,MYT1L
398,GO_Biological_Process_2017b,negative regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902894),1/488,0.3899955697577643,0.3997454590017084,0,0,2.106668107640765,1.9836806118354031,MYT1L
388,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter by histone modification (GO:1903758),1/482,0.3862311934886067,0.3997454590017084,0,0,2.133603238866397,2.02973760246591,MYT1L
377,GO_Biological_Process_2017b,negative regulation of cellular response to alkaline pH by negative regulation of transcription from RNA polymerase II promoter (GO:1900463),1/481,0.3856016558621654,0.3997454590017084,0,0,2.138157894736842,2.037558468106244,MYT1L
364,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter involved in meiotic cell cycle (GO:0010674),1/481,0.3856016558621654,0.3997454590017084,0,0,2.138157894736842,2.037558468106244,MYT1L
375,GO_Biological_Process_2017b,negative regulation of phosphatidylserine biosynthetic process by negative regulation of transcription from RNA polymerase II promoter (GO:1900526),1/481,0.3856016558621654,0.3997454590017084,0,0,2.138157894736842,2.037558468106244,MYT1L
376,GO_Biological_Process_2017b,"negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled (GO:2000805)",1/481,0.3856016558621654,0.3997454590017084,0,0,2.138157894736842,2.037558468106244,MYT1L
362,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter in response to iron (GO:0034396),1/481,0.3856016558621654,0.3997454590017084,0,0,2.138157894736842,2.037558468106244,MYT1L
363,GO_Biological_Process_2017b,negative regulation of cellular hyperosmotic salinity response by negative regulation of transcription from RNA polymerase II promoter (GO:1900464),1/481,0.3856016558621654,0.3997454590017084,0,0,2.138157894736842,2.037558468106244,MYT1L
365,GO_Biological_Process_2017b,regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter (GO:0072362),1/481,0.3856016558621654,0.3997454590017084,0,0,2.138157894736842,2.037558468106244,MYT1L
367,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter involved in heart development (GO:1901227),1/481,0.3856016558621654,0.3997454590017084,0,0,2.138157894736842,2.037558468106244,MYT1L
368,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter by pheromones (GO:0046020),1/481,0.3856016558621654,0.3997454590017084,0,0,2.138157894736842,2.037558468106244,MYT1L
366,GO_Biological_Process_2017b,regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter (GO:0072365),1/481,0.3856016558621654,0.3997454590017084,0,0,2.138157894736842,2.037558468106244,MYT1L
370,GO_Biological_Process_2017b,regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter (GO:0072368),1/481,0.3856016558621654,0.3997454590017084,0,0,2.138157894736842,2.037558468106244,MYT1L
371,GO_Biological_Process_2017b,regulation of transport by negative regulation of transcription from RNA polymerase II promoter (GO:1900392),1/481,0.3856016558621654,0.3997454590017084,0,0,2.138157894736842,2.037558468106244,MYT1L
372,GO_Biological_Process_2017b,negative regulation of filamentous growth of a population of unicellular organisms in response to starvation by negative regulation of transcription from RNA polymerase II promoter (GO:1902352),1/481,0.3856016558621654,0.3997454590017084,0,0,2.138157894736842,2.037558468106244,MYT1L
373,GO_Biological_Process_2017b,negative regulation of ribosomal protein gene transcription from RNA polymerase II promoter (GO:0010688),1/481,0.3856016558621654,0.3997454590017084,0,0,2.138157894736842,2.037558468106244,MYT1L
374,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter in response to copper ion (GO:0061398),1/481,0.3856016558621654,0.3997454590017084,0,0,2.138157894736842,2.037558468106244,MYT1L
369,GO_Biological_Process_2017b,negative regulation of pseudohyphal growth by negative regulation of transcription from RNA polymerase II promoter (GO:1900462),1/481,0.3856016558621654,0.3997454590017084,0,0,2.138157894736842,2.037558468106244,MYT1L
400,GO_Biological_Process_2017b,regulation of reactive oxygen species metabolic process by negative regulation of transcription from RNA polymerase II promoter (GO:1904489),1/492,0.3924929574474498,0.3998064908160358,0,0,2.089077071497481,1.95378151449212,MYT1L
399,GO_Biological_Process_2017b,negative regulation of cell-cell adhesion by negative regulation of transcription from RNA polymerase II promoter (GO:1900387),1/491,0.3918695227574201,0.3998064908160358,0,0,2.093447905477981,1.9611971491238585,MYT1L
401,GO_Biological_Process_2017b,negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter (GO:1900477),1/496,0.3949806299732015,0.4010948812111767,0,0,2.071770334928229,1.924505902345144,MYT1L
402,GO_Biological_Process_2017b,negative regulation of neuron apoptotic process by negative regulation of transcription from RNA polymerase II promoter (GO:1904089),1/534,0.4181357689250886,0.4232979389118181,0,0,1.9203120371284683,1.6744143393479567,MYT1L
403,GO_Biological_Process_2017b,phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),1/596,0.4541175916018518,0.4583094462935611,0,0,1.7147279964617426,1.3536047408209009,MYT1L
64,GO_Biological_Process_2018,negative regulation of transcription from RNA polymerase II promoter (GO:0000122),1/565,0.4363994094958315,0.483396268979998,0,0,1.811870100783875,1.5023979371185383,MYT1L
65,GO_Biological_Process_2018,regulation of nucleic acid-templated transcription (GO:1903506),1/607,0.4602765033761677,0.5021198218649102,0,0,1.68264721208963,1.30561287697696,TOX
66,GO_Biological_Process_2018,regulation of cellular macromolecule biosynthetic process (GO:2000112),1/631,0.4734857792129917,0.5088205388557523,0,0,1.6165413533834587,1.2085803085101006,TOX
67,GO_Biological_Process_2018,"regulation of transcription, DNA-templated (GO:0006355)",2/1598,0.4825533941520838,0.5109388879257358,0,0,1.2798663324979114,0.93259214101725,MYT1L;TOX
404,GO_Biological_Process_2017b,regulation of transcription from RNA polymerase II promoter (GO:0006357),1/736,0.5277495457296661,0.5309872730040812,0,0,1.3780880773361976,0.8807821914364968,MYT1L
68,GO_Biological_Process_2018,"negative regulation of transcription, DNA-templated (GO:0045892)",1/813,0.5641195497860438,0.5886464867332631,0,0,1.2424163857920665,0.7112698164624189,MYT1L
405,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter (GO:0000122),1/991,0.6382810672922778,0.6402329971616731,0,0,1.009569377990431,0.4532729746028061,MYT1L
69,GO_Biological_Process_2018,cellular protein modification process (GO:0006464),1/1001,0.642069743741414,0.6604145935625972,0,0,0.9989473684210526,0.442591968874904,PTPRD
70,GO_Biological_Process_2018,regulation of gene expression (GO:0010468),1/1037,0.6553992129340424,0.6646301877640993,0,0,0.962406015037594,0.4066268810703781,TOX
406,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter (GO:0045944),1/1175,0.702255741796215,0.702255741796215,0,0,0.8430915448758182,0.2979971450124291,MYT1L
71,GO_Biological_Process_2018,regulation of transcription from RNA polymerase II promoter (GO:0006357),1/1478,0.7848059250539295,0.7848059250539295,0,0,0.659337918255354,0.1597699869899741,MYT1L
